• Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
765
On Slideshare
0
From Embeds
0
Number of Embeds
1

Actions

Shares
Downloads
16
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Synthetic Biology: Emerging Global MarketsPublished:September 2011No.Of Pages:264Price:US $ 4850Report SummaryThis Report:* The global market for synthetic biology generated $233.8 million in 2008. This isexpected to increase to $2.4 billion in 2013, for a compound annual growth rate(CAGR) of 59.8%.* The chemicals and energy segment has the largest share of the market, worth$80.6 million in 2008. This should reach $1.6 billion in 2013, for a CAGR of 81.6%.* The biotechnology and pharmaceuticals segment is the second-largest marketsegment, worth 80.3 million in 2008. This segment is projected to increase at aCAGR of 49.2% to reach $594 million in 2013.Browse All Biotechnology Market Research ReportsTable of ContentsCHAPTER ONE: INTRODUCTIONSTUDY GOALS AND OBJECTIVESREASONS FOR DOING THE STUDYINTENDED AUDIENCESCOPE OF REPORTMETHODOLOGYINFORMATION SOURCESRELATED BCC REPORTSANALYST CREDENTIALSBCC ONLINE SERVICESDISCLAIMERCHAPTER TWO: SUMMARYSUMMARYSUMMARY TABLE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY,THROUGH 2013 ($ MILLIONS)SUMMARY FIGURE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY,2006-2013 ($ MILLIONS)SUMMARY (CONTINUED)
  • 2. CHAPTER THREE: OVERVIEWSYNTHETIC BIOLOGY TECHNOLOGIES COVERED IN THIS REPORTTABLE 1 SCOPE OF THIS REPORTWHAT IS SYNTHETIC BIOLOGY?WHAT IS SYNTHETIC BIOLOGY (CONTINUED)DEVELOPMENT STAGE OF SYNTHETIC BIOLOGYFORCES DRIVING SYNTHETIC BIOLOGY MARKET GROWTHTABLE 2 SYNTHETIC BIOLOGY GROWTH DRIVING FORCESTABLE 2 (CONTINUED)GLOBAL MARKET POTENTIAL FOR SYNTHETIC BIOLOGY PRODUCTSTABLE 3 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER,THROUGH 2013 ($ MILLIONS)TABLE 4 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGYMARKET BY FUEL TYPE, THROUGH 2013 ($ MILLIONS)LIFE CYCLE STATUS OF SYNTHETIC BIOLOGY TECHNOLOGIESTABLE 5 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLESTAGETHE SYNTHETIC BIOLOGY INDUSTRYTABLE 6 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUSTHE SYNTHETIC BIOLOGY INDUSTRY (CONTINUED)CHAPTER FOUR: SYNTHETIC BIOLOGY TECHNOLOGIESINTRODUCTIONDEFINITION OF SYNTHETIC BIOLOGYTABLE 7 SYNTHETIC BIOLOGY DEFINITIONSHISTORY OF SYNTHETIC BIOLOGYTABLE 8 SYNTHETIC BIOLOGY HISTORYPARADIGM SHIFT IN BIOLOGYTABLE 9 PARADIGM SHIFT OF BIOLOGY
  • 3. TABLE 10 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPAREDFIGURE 1 SCALE OF SYNTHETIC BIOLOGYSYNTHETIC BIOLOGY TECHNOLOGY OVERVIEWTABLE 11 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGYENABLING TECHNOLOGIESTABLE 12 IMPORTANCE OF ENABLING TECHNOLOGIESCOSTS OF DNA SYNTHESIS AND SEQUENCINGFIGURE 2 DNA SYNTHESIS AND SEQUENCING COSTS, 1990-2008 ($)FIGURE 3 HUMAN GENOME SEQUENCING COSTS, 1990-2015 ($)DNA SYNTHESIS TECHNOLOGIESFIGURE 4 SIMPLIFIED SCHEMATIC OF GENE SYNTHESIS TECHNOLOGYDNA Synthesis … (Continued)TABLE 13 COMPARISON OF GENE SYNTHESIS TECHNOLOGIESPCR-Based ApproachesSolid-Phase ApproachesMICROFLUIDICS TECHNOLOGIESTABLE 14 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETICBIOLOGYDNA Microarrays—Oligos SynthesisTABLE 15 MICROARRAY TYPESTABLE 16 DNA MICROARRAY PLATFORM FEATURESTABLE 17 DNA MICROARRAY PLATFORM COMPARISON FOR MAJORMANUFACTURERSTABLE 17 (CONTINUED)DNA Microarrays—…(Continued)
  • 4. FIGURE 5 MICROARRAYS IN GENE SYNTHESISDNA SEQUENCING TECHNOLOGIESDNA Sequencing TECHNOLOGIES (continued)FIGURE 6 SEQUENCING THROUGHPUT TREND, 1977-2008FIGURE 7 DNA SEQUENCING TECHNOLOGIESBIOINFORMATICS TECHNOLOGIESTABLE 18 SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIESBIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS TECHNOLOGIESTABLE 19 NUCLEIC ACIDS, GENES, AND GENOMESSYNTHETIC GENESTABLE 20 SYNTHETIC GENES AS MOLECULAR BIOLOGY TOOLSynthetic Genes (Continued)TABLE 21 SYNTHETIC GENES VERSUS PCR CLONINGBIOBRICKS/IGEM PARTSTABLE 22 BIOBRICKS/IGEM PARTSFIGURE 8 ROLE OF PROMOTERS AND REPORTERS IN SYNTHETIC BIOLOGYSYSTEMSMINIMAL GENOMES AND CHASSIS ORGANISMSTABLE 23 ATTRIBUTES OF A MINIMAL GENOMEMinimal Genomes and … (Continued)CASE STUDY: MINIMAL E.COLI GENOMERole of Directed Evolution in Designing Biologic PartsENABLED TECHNOLOGIESOVERVIEWTABLE 24 ENABLED TECHNOLOGIES: EXISTING AND NEAR-TERMAPPLICATIONSPathway Engineering
  • 5. FIGURE 9 HOW SYNTHETIC BIOLOGY CREATES ENABLED PRODUCTSTABLE 25 METABOLIC ENGINEERING FOR ARTEMISINIC ACIDSynthetic Microbial ConsortiaTABLE 26 APPLICATIONS FOR SYNTHETIC MICROBIAL CONSORTIABIOFUELS TECHNOLOGIESBiofuels FeedstocksTABLE 27 ENERGY BALANCE OF SELECTED FIRST-GENERATION BIOFUELFEEDSTOCKSAdvanced-Generation BiofuelsTABLE 28 FIRST- AND ADVANCED-GENERATION BIOFUELS COMPAREDCellulosic BiomassFIGURE 10 APPROXIMATE COMPOSITION OF CELLULOSIC BIOMASS (%)TABLE 29 SYNTHETIC BIOLOGY STRATEGIES FOR CONVERTINGCELLULOSIC BIOMASS INTO ETHANOLBiofuels TypesTABLE 30 EFFICIENCY OF VARIOUS FUELSCellulosic EthanolFIGURE 11 CELLULOSIC ETHANOL PRODUCTION SCHEMATICTABLE 31 CORN ETHANOL COST TARGETS, 2009 ($/GAL. OF ETHANOL)FIGURE 12 ESTIMATED 25 MGY CELLULOSIC ETHANOL PLANT COSTS (%)BiodieselTABLE 32 IODINE NUMBER OF VARIOUS OILSOther BiofuelsRole of Genetic Engineering and Synthetic Biology in Biofuels
  • 6. TABLE 33 CONTRIBUTION OF SYNTHETIC BIOLOGY TO BIOFUELSCHAPTER FIVE: SYNTHETIC BIOLOGY APPLICATIONSINTRODUCTIONENABLING TECHNOLOGIESTABLE 34 SYNTHETIC BIOLOGY PRODUCTS IMPACTED BY ENABLINGTECHNOLOGIESBIOLOGIC COMPONENTS AND INTEGRATED SYSTEMS APPLICATIONSTABLE 35 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS NEAR-TERM APPLICATIONSSYNTHETIC GENE APPLICATIONSTABLE 36 SYNTHETIC GENES NEAR-TERM APPLICATIONSSynthetic Gene Applications (Continued)Synthetic Gene Applications (Continued)BIOBRICKS/IGEM PARTS APPLICATIONSINTEGRATED SYSTEMS APPLICATIONSSynthetic Cells and TissuesENABLED PRODUCTS APPLICATIONSTABLE 37 ENABLED PRODUCTS NEAR-TERM APPLICATIONSAPPLICATIONS BY END-USER INDUSTRYRESEARCH AND DEVELOPMENT APPLICATIONSTABLE 38 RESEARCH & DEVELOPMENT APPLICATIONS FOR SYNTHETICBIOLOGY PRODUCTSPHARMACEUTICALS APPLICATIONSTABLE 39 DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS FORSYNTHETIC BIOLOGY PRODUCTSPharmaceuticals Applications (Continued)TABLE 40 PIPELINE OF SYNTHETIC BIOLOGY-ENABLED DRUGSENERGY APPLICATIONSTABLE 41 ETHANOL AND BIODIESEL FEEDSTOCKS AND PRODUCTIONPROCESSES
  • 7. TABLE 42 ETHANOL AND BIODIESEL COMMON BLENDSTABLE 43 FIRST-GENERATION FUEL ETHANOL GLOBAL PRODUCTION ANDGOALS, 2007 (MILLION GALS.)TABLE 44 FIRST-GENERATION BIODIESEL PRODUCTION AND GOALS, 2007(MILLION GALS.)United StatesFIGURE 13 RENEWABLE FUELS STANDARDS, UNITED STATES, 2008-2013(BILLION GALS./ YR)TABLE 45 DOE FUNDING FOR CELLULOSIC BIOFUELS, 2007-2011 ($MILLIONS)CanadaBrazilCHEMICAL INDUSTRY APPLICATIONSChemical Industry Applications (Continued)CHAPTER SIX: SYNTHETIC BIOLOGY INDUSTRYINDUSTRIAL BIOTECHNOLOGY VALUE CHAINFIGURE 14 INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN WITH SYNTHETICBIOLOGY LEVERAGE POINTSINDUSTRY STRUCTURAL FORCESTABLE 46 SYNTHETIC BIOLOGY INDUSTRY STRUCTURAL FORCESINDUSTRY STRUCTURAL FORCES (CONTINUED)PRODUCTS AND TECHNOLOGY LIFE CYCLETABLE 47 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLESTAGEINDUSTRY COMPETITOR POSITIONINGTABLE 48 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUSGENE SYNTHESIS INDUSTRYGENE SYNTHESIS WORKFLOWTABLE 49 GENE SYNTHESIS WORKFLOWGene Synthesis Workflow (Continued)
  • 8. GENE SYNTHESIS COMPETITOR STRATEGIESFIGURE 15 SYNTHETIC GENE COMPANY ESTIMATED MARKET SHARES, 2008(%)Gene Synthesis … (Continued)TABLE 50 SYNTHETIC GENE KEY COMPETITOR STRATEGIESGene Synthesis … (Continued)Gene Synthesis Value ChainSynthetic Gene Market SegmentsAutomated, Standardized Market SegmentValue-Added Market SegmentsTABLE 51 GENE SYNTHESIS MARKET FACTORS OF DIFFERENTIATIONBIOFUELS INDUSTRYCOMPETITIVE DIFFERENTIATIONFEEDSTOCKSTABLE 52 BIOFUELS: FEEDSTOCKS, PRODUCTION, AND PRODUCTSFIGURE 16 BIOFUELS FEEDSTOCKS: RELATIVE COSTS AND VOLUMESSugars/StarchesVegetable OilsBiomassAlgaeTABLE 53 BIODIESEL YIELD OF SELECTED CROPS (GALS./ACRE/YR.)CO2CELLULOSIC ETHANOL INDUSTRYTABLE 54 CELLULOSIC ETHANOL PLANTS (MGY)Cellulosic Ethanol Industry (Continued)BIOFUELS COMPETITOR STRATEGIESTABLE 55 SYNTHETIC BIOLOGY-BASED BIOFUELS COMPANY STRATEGIESTABLE 55 (CONTINUED)AgrividaAmyrisBP 116
  • 9. DuPontGevoLS9MascomaOpX BiotechnologiesSequescoSolazymeSynthetic GenomicsVerdezyneVereniumROLE OF BIOFUELS FOUNDERS AND INVESTORSTABLE 56 ROLE OF INVESTORS AND FOUNDERS IN BIOFUELS COMPANIESENZYMES INDUSTRYTABLE 57 ENZYME COMPANY KEY ALLIANCESPHARMACEUTICALS INDUSTRYTABLE 58 PHARMACEUTICALS COMPANY STRATEGIESINDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCESTABLE 59 INDUSTRY ACQUISITIONS, 2006-2008TABLE 60 SYNTHETIC BIOLOGY STRATEGIC ALLIANCES, 2006-2009TABLE 60 (CONTINUED)TABLE 60 (CONTINUED)BIODEFENSE ISSUESTABLE 61 FUTURE SYNTHETIC BIOLOGY SECURITY REGULATIONSSUPPORTING INDUSTRY ORGANIZATIONSTABLE 62 SYNTHETIC BIOLOGY ENABLING ORGANIZATIONSTABLE 62 (CONTINUED)SUPPORTING INDUSTRY … (CONTINUED)FIGURE 17 GROWTH IN IGEM (NUMBER)CHAPTER SEVEN: SYNTHETIC BIOLOGY MARKETS
  • 10. GROWTH DRIVING FORCESTABLE 63 SYNTHETIC BIOLOGY GROWTH DRIVING FORCESFIGURE 18 NIH BUDGET OUTLAYS, 2000-2009 ($ BILLIONS)FIGURE 19 SYNTHETIC BIOLOGY RESEARCH PUBLICATIONS, 2000-2008(NUMBER)MARKET FORECASTSFIGURE 20 MARKET FORECAST SCENARIO TABLESYNTHETIC BIOLOGY MARKETS BY INDUSTRYSummaryTABLE 64 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER,THROUGH 2013 ($ MILLIONS)R&D MarketTABLE 65 GLOBAL VALUE OF R&D MARKET BY APPLICATION, THROUGH2013 ($ MILLIONS)Biotechnology and Pharmaceuticals MarketTABLE 66 GLOBAL VALUE OF BIOTECHNOLOGY AND PHARMACEUTICALSMARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)Chemicals MarketTABLE 67 GLOBAL VALUE OF CHEMICALS MARKET BY PRODUCT TYPE,THROUGH 2013 ($ MILLIONS)Energy MarketTABLE 68 GLOBAL VALUE OF ENERGY MARKET BY PRODUCT TYPE,THROUGH 2013 ($ MILLIONS)FIGURE 21 S-CURVE FOR SECOND-GENERATION BIOFUELSTABLE 69 WORLD BIODIESEL PRODUCTION AND CAPACITY TRENDS, 2002-2008 (MILLIONS TONS/YR)TABLE 70 GLOBAL BIOFUELS SUPPLY BY PRODUCT CLASS, THROUGH 2013(KBOED)
  • 11. FIGURE 22 GLOBAL BIOFUELS MARKET, 2013 (GALS./YR.)FIGURE 22 (CONTINUED)FIGURE 23 GLOBAL CELLULOSIC SECOND-GENERATION BIOFUELS MARKET,2013 (GALS./YR)FIGURE 23 (CONTINUED)FIGURE 24 UNITED STATES BIOFUELS MARKET GOALS, 2022 (%)SYNTHETIC BIOLOGY MARKETS BY PRODUCT TYPESummaryTABLE 71 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY PRODUCTTYPE, THROUGH 2013 ($ MILLIONS)Summary (Continued)Enabling Products MarketTABLE 72 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLING PRODUCTSMARKET, THROUGH 2013 ($ MILLIONS)Biological Parts MarketTABLE 73 GLOBAL VALUE OF DNA SYNTHESIS MARKET BY TYPE, THROUGH2013 ($ MILLIONS)TABLE 74 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY TYPE, THROUGH2013 ($ MILLIONS)Standardized Market SegmentValue-Added Market SegmentsTABLE 75 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY END USERINDUSTRY, THROUGH 2013 ($ MILLIONS)TABLE 76 GLOBAL VALUE OF BIOLOGIC PARTS BY SUPPLIER TYPE,THROUGH 2013 ($ MILLIONS)TABLE 77 HOMEBREW VERSUS COMMERCIAL COST COMPARISON FORSYNTHESIZING A TYPICAL 714 BP GFP GENE ($)Integrated Systems MarketTABLE 78 GLOBAL VALUE OF SYNTHETIC BIOLOGY INTEGRATED SYSTEMS
  • 12. MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)Enabled Products MarketTABLE 79 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED PRODUCTSMARKET BY INDUSTRY, THROUGH 2013 ($ MILLIONS)TABLE 80 GLOBAL VALUE OF ENABLED R&D MARKET BY PRODUCT TYPE,THROUGH 2013 ($ MILLIONS)TABLE 81 GLOBAL VALUE OF ENABLED PHARMACEUTICALS MARKET BYPRODUCT TYPE, THROUGH 2013 ($ MILLIONS)TABLE 82 GLOBAL VALUE OF ENABLED CHEMICALS MARKET BY PRODUCTTYPE, THROUGH 2013 ($ MILLIONS)TABLE 82 (CONTINUED)TABLE 83 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGYMARKET BY FUEL TYPE, THROUGH 2013 ($ MILLIONS)SYNTHETIC BIOLOGY MARKET BY GEOGRAPHIC REGIONSummaryTABLE 84 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BYGEOGRAPHIC REGION, THROUGH 2013 ($ MILLIONS)Importance of Geography to Fuels MarketsImportance of Geography … (Continued)CHAPTER EIGHT: PATENT STATUSINTRODUCTIONFOUNDATIONAL PATENTSTABLE 85 SYNTHETIC BIOLOGY FOUNDATIONAL PATENTSSYNTHETIC BIOLOGY INDUSTRY PATENT ANALYSISSYNTHETIC BIOLOGY INDUSTRY (continued)FIGURE 25 NUMBER OF PATENTS BY COMPANYFIGURE 25 (CONTINUED)TABLE 86 PATENT DESCRIPTION BY COMPANY
  • 13. FIGURE 26 SYNTHETIC BIOLOGY PATENTS BY COMPANY AND SUBCLASS(NUMBER OF PATENTS)FIGURE 26 (CONTINUED)LITIGATION STATUSTABLE 87 IP LITIGATION STATUSIP STRATEGY OF SELECTED SYNTHETIC BIOLOGY COMPANIESMETABOLIXDUPONTGENEARTFEBITCHAPTER NINE: COMPANY PROFILESAGRIVIDAAMYRIS BIOTECHNOLOGIES, INC.TABLE 88 AMYRIS BIODIESEL ADVANTAGESATG BIOSYNTHETICS GMBHBASF AGBIO BASIC, INC.BIOCAT GMBHBIONEER CORP.BIONEXUS, INC.BIO S&T, INC.BIOTICA TECHNOLOGY, LTD.BIOTICA TECHNOLOGY, LTD. (CONTINUED)TABLE 89 STRUCTURE-FUNCTION APPROACH FOR RAPAMYCINTABLE 90 BIOTICA PROJECTS PIPELINEBLUE HERON BIOTECHNOLOGIESBRISTOL-MYERS SQUIBBBRISTOL-MYERS SQUIBB (CONTINUED)BRITISH PETROLEUMCELLICON BIOTECHNOLOGIES, INC.CODEXIS, INCCODON DEVICES, INC.DANISCO A/SDNA 2.0TABLE 91 DNA2.0 STRATEGIC ALLIANCES
  • 14. DRATHS CORPDUPONTDUPONT (CONTINUED)DYADIC INTERNATIONAL, INC.ENTELECHON GMBHEPOCH BIOLABS, INC.ERAGEN BIOSCIENCES, INC.EUROFINS MEDIGENOMIX GMBHEUROFINS MWG OPERONFEBIT SYNBIO GMBHGENEART AGTABLE 92 GENEART MAJOR STRATEGIC ALLIANCESGENEART AG (CONTINUED)GENEMED SYNTHESIS, INC.GENSCRIPT CORP.GENEWORKS PTY, LTD.GEVO, INC.TABLE 93 GEVO ISOBUTANOL PRODUCTION FORECAST (GALS./YR.)HELICOS BIOSCIENCES CORP.HELICOS BIOSCIENCES CORP. (CONTINUED)HELICOS BIOSCIENCES CORP. (CONTINUED)INTEGRATED DNA TECHNOLOGIESILLUMINA, INC.ILLUMINA, INC. (CONTINUED)INSTITUTE FOR ONEWORLD HEALTHIOGEN CORP.JOULE BIOTECHNOLOGIES, INC.KHOSLA VENTURESTABLE 94 KHOSLA VENTURES BIOFUELS INVESTMENT PORTFOLIOLC SCIENCESLIFE TECHNOLOGIESLIFE TECHNOLOGIES (CONTINUED)LS9, INC.MASCOMATABLE 95 MASCOMA INTELLECTUAL PROPERTY STATUSMAXYGENMERCK & CO.METABOLIX, INC.
  • 15. TABLE 96 METABOLOMIX BUSINESS STRATEGYMETRIGEN, INC.NOVOZYMES A/SOMEGA BIO-TEK, INC.OPX BIOTECHNOLOGIES, INC.PACIFIC BIOSCIENCESPFIZERPROTOLIFE SRLQTEROSROCHE LIFE SCIENCESROCHE LIFE SCIENCES (CONTINUED)ROYAL DSM N.V.SANGAMO BIOSCIENCES, INC.SANGAMO BIOSCIENCES, INC. (CONTINUED)SANOFI AVENTISSCARAB GENOMICS, LLCSEQUESCOSLONING BIOTECHNOLOGY, GMBHSOLAZYME, INC.TABLE 97 SOLAZYME STRATEGIC ALLIANCESSYNTHETIC GENOMICSSYNTHETIC GENOMICS (CONTINUED)TABLE 98 SYNTHETIC GENOMICS STRATEGIC ALLIANCESVERDEZYNETABLE 99 VERDEZYNE STRATEGIC COLLABORATIONSVERENIUM CORP.VERENIUM CORP. (CONTINUED)LIST OF TABLESSUMMARY TABLE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY,THROUGH 2013 ($ MILLIONS)TABLE 1 SCOPE OF THIS REPORTTABLE 2 SYNTHETIC BIOLOGY GROWTH DRIVING FORCESTABLE 3 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER,THROUGH 2013 ($ MILLIONS)TABLE 4 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BYFUEL TYPE, THROUGH 2013 ($ MILLIONS)TABLE 5 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGETABLE 6 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
  • 16. TABLE 7 SYNTHETIC BIOLOGY DEFINITIONSTABLE 8 SYNTHETIC BIOLOGY HISTORYTABLE 9 PARADIGM SHIFT OF BIOLOGYTABLE 10 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPAREDTABLE 11 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGYTABLE 12 IMPORTANCE OF ENABLING TECHNOLOGIESTABLE 13 COMPARISON OF GENE SYNTHESIS TECHNOLOGIESTABLE 14 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETICBIOLOGYTABLE 15 MICROARRAY TYPESTABLE 16 DNA MICROARRAY PLATFORM FEATURESTABLE 17 DNA MICROARRAY PLATFORM COMPARISON FOR MAJORMANUFACTURERSTABLE 18 SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIESTABLE 19 NUCLEIC ACIDS, GENES, AND GENOMESTABLE 20 SYNTHETIC GENES AS MOLECULAR BIOLOGY TOOLTABLE 21 SYNTHETIC GENES VERSUS PCR CLONINGTABLE 22 BIOBRICKS/IGEM PARTSTABLE 23 ATTRIBUTES OF A MINIMAL GENOMETABLE 24 ENABLED TECHNOLOGIES: EXISTING AND NEAR-TERM APPLICATIONSTABLE 25 METABOLIC ENGINEERING FOR ARTEMISINIC ACIDTABLE 26 APPLICATIONS FOR SYNTHETIC MICROBIAL CONSORTIATABLE 27 ENERGY BALANCE OF SELECTED FIRST-GENERATION BIOFUELFEEDSTOCKSTABLE 28 FIRST- AND ADVANCED-GENERATION BIOFUELS COMPAREDTABLE 29 SYNTHETIC BIOLOGY STRATEGIES FOR CONVERTING CELLULOSICBIOMASS INTO ETHANOLTABLE 30 EFFICIENCY OF VARIOUS FUELSTABLE 31 CORN ETHANOL COST TARGETS, 2009 ($/GAL. OF ETHANOL)TABLE 32 IODINE NUMBER OF VARIOUS OILSTABLE 33 CONTRIBUTION OF SYNTHETIC BIOLOGY TO BIOFUELSTABLE 34 SYNTHETIC BIOLOGY PRODUCTS IMPACTED BY ENABLINGTECHNOLOGIESTABLE 35 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS NEAR-TERMAPPLICATIONSTABLE 36 SYNTHETIC GENES NEAR-TERM APPLICATIONSTABLE 37 ENABLED PRODUCTS NEAR-TERM APPLICATIONSTABLE 38 RESEARCH & DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGYPRODUCTSTABLE 39 DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS FOR SYNTHETICBIOLOGY PRODUCTSTABLE 40 PIPELINE OF SYNTHETIC BIOLOGY-ENABLED DRUGSTABLE 41 ETHANOL AND BIODIESEL FEEDSTOCKS AND PRODUCTION PROCESSESTABLE 42 ETHANOL AND BIODIESEL COMMON BLENDSTABLE 43 FIRST-GENERATION FUEL ETHANOL GLOBAL PRODUCTION AND GOALS,2007 (MILLION GALS.)TABLE 44 FIRST-GENERATION BIODIESEL PRODUCTION AND GOALS, 2007
  • 17. (MILLION GALS.)TABLE 45 DOE FUNDING FOR CELLULOSIC BIOFUELS, 2007-2011 ($ MILLIONS)TABLE 46 SYNTHETIC BIOLOGY INDUSTRY STRUCTURAL FORCESTABLE 47 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGETABLE 48 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUSTABLE 49 GENE SYNTHESIS WORKFLOWTABLE 50 SYNTHETIC GENE KEY COMPETITOR STRATEGIESTABLE 51 GENE SYNTHESIS MARKET FACTORS OF DIFFERENTIATIONTABLE 52 BIOFUELS: FEEDSTOCKS, PRODUCTION, AND PRODUCTSTABLE 53 BIODIESEL YIELD OF SELECTED CROPS (GALS./ACRE/YR.)TABLE 54 CELLULOSIC ETHANOL PLANTS (MGY)TABLE 55 SYNTHETIC BIOLOGY-BASED BIOFUELS COMPANY STRATEGIESTABLE 56 ROLE OF INVESTORS AND FOUNDERS IN BIOFUELS COMPANIESTABLE 57 ENZYME COMPANY KEY ALLIANCESTABLE 58 PHARMACEUTICALS COMPANY STRATEGIESTABLE 59 INDUSTRY ACQUISITIONS, 2006-2008TABLE 60 SYNTHETIC BIOLOGY STRATEGIC ALLIANCES, 2006-2009TABLE 61 FUTURE SYNTHETIC BIOLOGY SECURITY REGULATIONSTABLE 62 SYNTHETIC BIOLOGY ENABLING ORGANIZATIONSTABLE 63 SYNTHETIC BIOLOGY GROWTH DRIVING FORCESTABLE 64 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER,THROUGH 2013 ($ MILLIONS)TABLE 65 GLOBAL VALUE OF R&D MARKET BY APPLICATION, THROUGH 2013 ($MILLIONS)TABLE 66 GLOBAL VALUE OF BIOTECHNOLOGY AND PHARMACEUTICALS MARKETBY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)TABLE 67 GLOBAL VALUE OF CHEMICALS MARKET BY PRODUCT TYPE, THROUGH2013 ($ MILLIONS)TABLE 68 GLOBAL VALUE OF ENERGY MARKET BY PRODUCT TYPE, THROUGH 2013($ MILLIONS)TABLE 69 WORLD BIODIESEL PRODUCTION AND CAPACITY TRENDS, 2002-2008(MILLIONS TONS/YR)TABLE 70 GLOBAL BIOFUELS SUPPLY BY PRODUCT CLASS, THROUGH 2013(KBOED)TABLE 71 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY PRODUCT TYPE,THROUGH 2013 ($ MILLIONS)TABLE 72 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLING PRODUCTS MARKET,THROUGH 2013 ($ MILLIONS)TABLE 73 GLOBAL VALUE OF DNA SYNTHESIS MARKET BY TYPE, THROUGH 2013 ($MILLIONS)TABLE 74 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY TYPE, THROUGH 2013($ MILLIONS)TABLE 75 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY END USER INDUSTRY,THROUGH 2013 ($ MILLIONS)TABLE 76 GLOBAL VALUE OF BIOLOGIC PARTS BY SUPPLIER TYPE, THROUGH 2013($ MILLIONS)TABLE 77 HOMEBREW VERSUS COMMERCIAL COST COMPARISON FOR
  • 18. SYNTHESIZING A TYPICAL 714 BP GFP GENE ($)TABLE 78 GLOBAL VALUE OF SYNTHETIC BIOLOGY INTEGRATED SYSTEMS MARKETBY TYPE, THROUGH 2013 ($ MILLIONS)TABLE 79 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED PRODUCTS MARKETBY INDUSTRY, THROUGH 2013 ($ MILLIONS)TABLE 80 GLOBAL VALUE OF ENABLED R&D MARKET BY PRODUCT TYPE, THROUGH2013 ($ MILLIONS)TABLE 81 GLOBAL VALUE OF ENABLED PHARMACEUTICALS MARKET BY PRODUCTTYPE, THROUGH 2013 ($ MILLIONS)TABLE 82 GLOBAL VALUE OF ENABLED CHEMICALS MARKET BY PRODUCT TYPE,THROUGH 2013 ($ MILLIONS)TABLE 83 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BYFUEL TYPE, THROUGH 2013 ($ MILLIONS)TABLE 84 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY GEOGRAPHICREGION, THROUGH 2013 ($ MILLIONS)TABLE 85 SYNTHETIC BIOLOGY FOUNDATIONAL PATENTSTABLE 86 PATENT DESCRIPTION BY COMPANYTABLE 87 IP LITIGATION STATUSTABLE 88 AMYRIS BIODIESEL ADVANTAGESTABLE 89 STRUCTURE-FUNCTION APPROACH FOR RAPAMYCINTABLE 90 BIOTICA PROJECTS PIPELINETABLE 91 DNA2.0 STRATEGIC ALLIANCESTABLE 92 GENEART MAJOR STRATEGIC ALLIANCESTABLE 93 GEVO ISOBUTANOL PRODUCTION FORECAST (GALS./YR.)TABLE 94 KHOSLA VENTURES BIOFUELS INVESTMENT PORTFOLIOTABLE 95 MASCOMA INTELLECTUAL PROPERTY STATUSTABLE 96 METABOLOMIX BUSINESS STRATEGYTABLE 97 SOLAZYME STRATEGIC ALLIANCESTABLE 98 SYNTHETIC GENOMICS STRATEGIC ALLIANCESTABLE 99 VERDEZYNE STRATEGIC COLLABORATIONSLIST OF FIGURESSUMMARY FIGURE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY,2006-2013 ($ MILLIONS)FIGURE 1 SCALE OF SYNTHETIC BIOLOGYFIGURE 2 DNA SYNTHESIS AND SEQUENCING COSTS, 1990-2008 ($)FIGURE 3 HUMAN GENOME SEQUENCING COSTS, 1990-2015 ($)FIGURE 4 SIMPLIFIED SCHEMATIC OF GENE SYNTHESIS TECHNOLOGYFIGURE 5 MICROARRAYS IN GENE SYNTHESISFIGURE 6 SEQUENCING THROUGHPUT TREND, 1977-2008FIGURE 7 DNA SEQUENCING TECHNOLOGIESFIGURE 8 ROLE OF PROMOTERS AND REPORTERS IN SYNTHETIC BIOLOGYSYSTEMSFIGURE 9 HOW SYNTHETIC BIOLOGY CREATES ENABLED PRODUCTSFIGURE 10 APPROXIMATE COMPOSITION OF CELLULOSIC BIOMASS (%)FIGURE 11 CELLULOSIC ETHANOL PRODUCTION SCHEMATIC
  • 19. FIGURE 12 ESTIMATED 25 MGY CELLULOSIC ETHANOL PLANT COSTS (%)FIGURE 13 RENEWABLE FUELS STANDARDS, UNITED STATES, 2008-2013 (BILLIONGALS./ YR)FIGURE 14 INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN WITH SYNTHETICBIOLOGY LEVERAGE POINTSFIGURE 15 SYNTHETIC GENE COMPANY ESTIMATED MARKET SHARES, 2008 (%)FIGURE 16 BIOFUELS FEEDSTOCKS: RELATIVE COSTS AND VOLUMESFIGURE 17 GROWTH IN IGEMFIGURE 18 NIH BUDGET OUTLAYS, 2000-2009 ($ BILLIONS)FIGURE 19 SYNTHETIC BIOLOGY RESEARCH PUBLICATIONS, 2000-2008 (NUMBER)FIGURE 20 MARKET FORECAST SCENARIO TABLEFIGURE 21 S-CURVE FOR SECOND-GENERATION BIOFUELSFIGURE 22 GLOBAL BIOFUELS MARKET, 2013 (GALS./YR.)FIGURE 23 2013 GLOBAL CELLULOSIC SECOND-GENERATION BIOFUELS MARKET(GALS./YR)FIGURE 24 UNITED STATES BIOFUELS MARKET GOALS, 2022 (%)FIGURE 25 NUMBER OF PATENTS BY COMPANYFIGURE 26 SYNTHETIC BIOLOGY PATENTS BY COMPANY AND SUBCLASS (NUMBEROF PATENTS)About Us:ReportsnReports is an online library of over 100,000+ market research reports andin-depth market research studies & analysis of over 5000 micro markets. Weprovide 24/7 online and offline support to our customers. Get in touch with us foryour needs of market research reports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page:http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: + 1 888 391 5441E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comVisit our Market Research Blog